治疗失败的预测者在GH和前素共同分泌的垂体腺瘤中
Endocrine connections
|July 1, 2025
概括
预测生长激素和前素共同分泌的垂体腺瘤 (GH&PRL-PAs) 治疗失败的预测因素包括较高的瘤等级和高的GH/IGF-1水平. 这些因素还预测了对第一代体静止素受体连接体 (fgSRLs) 的耐药性.
科学领域:
- 内分泌学 在内分泌学.
- 神经外科 神经外科
- 在瘤学瘤学.
背景情况:
- 增长激素和前素共同分泌的垂体腺瘤 (GH&PRL-PAs) 存在独特的治疗挑战.
- 了解预测治疗失败的因素对于优化患者管理至关重要.
研究的目的:
- 确定与GH&PRL-PAs患者接受手术或第一代体静止素受体连接体 (fgSRL) 治疗的治疗失败相关的临床因素.
- 确定该患者群体中fgSRL治疗耐药性的预测因素.
主要方法:
- 从ACRO-SPAIN研究中对126名患有GH&PRL-PA的壮病患者进行了回顾性分析.
- 评估手术结果和对一线医学治疗的反应,包括fgSRLs.
- 统计分析以确定手术治愈和fgSRL耐药性的预测因素.
主要成果:
- 在42.1%的患者中实现了手术治愈. Knosp等级>2,较高的血清GH和IGF-1水平预测了较低的手术治愈率.
- 在单一治疗中使用fgSRL治疗的患者中,有18.2%的患者表现出抗药性.
- 诺斯普等级>2,在诊断时高GH,以及术后高GH水平预测了对fgSRLs (单疗或联合疗法) 的不反应.
结论:
- 在GH&PRL-PAs中,手术失败和fgSRL耐药性的临床预测因素与没有前素共分泌的壮病的临床预测因素相似.
- 瘤等级和GH/IGF-1水平是影响治疗结果的关键因素.
更多相关视频
12:34Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Published on: April 2, 2018
13.6K
09:48Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
4.2K
相关概念视频
Hormones of the Pituitary Gland
7.1K
The small, pea-sized pituitary gland is located at the base of the brain. It is crucial in regulating various bodily functions, from growth to reproduction. The gland is divided into the anterior lobe and the posterior lobe. The secretory cell clusters in the pars distalis of the anterior pituitary lobe are controlled by hypothalamic regulators and synthesize six primary hormones.
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
7.1K
Major Hormones and Their Functions
817
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
817
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
639
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
639
